Radiopharmaceuticals Air Transport Expansion Extends Access Across Saudi Arabia

King Faisal Specialist Hospital and Research Centre has started an air transport service for short half-life radiopharmaceuticals, aiming to speed delivery between regions in Saudi Arabia. The move is designed to support cancer diagnosis and treatment by ensuring these time-sensitive radioactive materials reach patients within strict clinical windows.

The new service follows a pilot flight that carried radiopharmaceuticals from the hospital’s main site in Riyadh to its branch in Jeddah. Relevant aviation and logistics bodies coordinated the operation, which tested both timing and safety procedures for handling radioactive medical materials during domestic flights.

Rapid transport is essential because radiopharmaceuticals lose effectiveness according to their radioactive half-life. Their medical value falls as time passes. Hospitals must therefore move these materials from production lines to patients within tightly controlled schedules, making air transport an important option for reaching different regions without affecting clinical performance.

The service was launched after King Faisal Specialist Hospital and Research Centre received a licence from the General Authority of Civil Aviation. The licence confirms the hospital met international technical and logistical standards for transporting radioactive materials. It also requires full compliance with national and global rules that govern highly sensitive medical isotopes.

By using air links instead of building multiple production plants, the hospital offers a long-term solution that reduces infrastructure demands. Radiopharmaceutical manufacturing sites need high investment, specialised equipment, and complex support systems. Central production with air distribution helps health authorities use budgets more efficiently while expanding nuclear medicine coverage nationwide.

This approach is expected to support more accurate imaging and better targeted therapies for cancer patients across Saudi Arabia. Faster delivery helps maintain radiopharmaceutical quality on arrival. It also allows advanced diagnostic services that depend on short half-life materials to be offered beyond major urban centres, including in remote regions.

Radiopharmaceuticals air transport and hospital global rankings

King Faisal Specialist Hospital and Research Centre has also received several international rankings and brand assessments linked to its clinical and research role. These recognitions place the institution among leading academic medical centres and highlight its regional position within the Middle East and Africa.

{TABLE_1}

The hospital ranked first in the Middle East and Africa and 15th worldwide among the top 250 academic medical centres for 2025. Brand Finance 2024 named it the most valuable healthcare brand in Saudi Arabia and the Middle East. Newsweek listed the hospital in the World’s Best Hospitals 2025, the World’s Best Smart Hospitals 2026, and the World’s Best Specialized Hospitals 2026.

With inputs from SPA